Patents Assigned to Sun Health Research Institute
  • Alpha and/or ?-adrenergic antagonists and agonists to treat pain
    Patent number: 7550466
    Abstract: The present disclosure provides for improved methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using ?-adrenergic antagonists and ?-adrenergic agonists (particularly ?2-adrenergic agonists) alone or in combination.
    Type: Grant
    Filed: October 15, 2007
    Date of Patent: June 23, 2009
    Assignee: Sun Health Research Institute
    Inventors: Cheri Lubahn, Dianne Lorton
  • Treatment of inflammatory autoimmune diseases with alpha-adrenergic antagonists and beta-adrenergic agonists
    Patent number: 7462618
    Abstract: The present invention discloses a novel compound and method for the treatment of inflammatory autoimmune diseases, for example, rheumatoid arthritis, using ?-adrenergic antagonists and ?-adrenergic agonists in combination. Treatment of animals, namely humans, with an ?-adrenergic antagonist, preferably, phentolamine, and a ?-adrenergic agonist, preferably terbutaline, in combination can significantly suppress the joint destruction and inflammation due to disease in these animals.
    Type: Grant
    Filed: August 27, 2004
    Date of Patent: December 9, 2008
    Assignee: Sun Health Research Institute
    Inventors: Dianne Lorton, Cheri Lubahn